Healthcare • Drug Manufacturers - General
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if JNJ is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
575 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 41 days ago
Red flags: 2
4,701 filers reported a long position in JNJ for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $53.9B | 212.1M | -0.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $39.9B | 157.2M | +0.4% |
| STATE STREET CORP | $34B | 133.8M | +0.2% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $16.3B | 64.4M | +1.3% |
| JPMORGAN CHASE & CO | $15.1B | 58.3M | -7.6% |
| GEODE CAPITAL MANAGEMENT, LLC | $15B | 59.1M | -0.1% |
| MORGAN STANLEY | $11.4B | 44.8M | +0.2% |
| NORGES BANK | $8.1B | 31.8M | — |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $8B | 31.6M | Unchanged |
| NORTHERN TRUST CORP | $7.3B | 28.8M | -1.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.